Cappell MS, Friedel D. Initial management of acute upper gastrointestinal bleeding: from initial evaluation up to gastrointestinal endoscopy. Med Clin North Am. 2008;92:491-509.
1. Mange K, Matsuura D, Cizman B, et al. Language guiding therapy: the case of dehydration versus volume depletion. Ann Intern Med. 1997;127:848-853.
2. McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination: is this patient hypovolemic? JAMA. 1999;281:1022-1029.
3. Batlle D, Chen S, Haque S. Physiological principles in the clinical evaluation of electrolyte, water, and acid-base disorders. In: Alpern RJ, Caplan MJ, Moe OW, eds. Seldin and Giebisch's the kidney: physiology and pathophysiology. 5th ed. San Diego, CA: Academic Press; 2012:2477-2512.
4. Di Somma S, Gori, CS, Grandi T, et al. Fluid assessment and management at the emergency department. Fluid overload diagnosis and management. Contrib Nephrol. 2010;164:227-236.
5. Rose BD, Post TW. Hypovolemic states. In: Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:415-446.
6. Bhave G, Neilson EG. Volume depletion versus dehydration: how understanding the difference can guide therapy. Am J Kidney Dis. 2011;58:302-309.
7. Alam NH, Majumder RM, Fuchs GJ. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. Lancet. 1999;354:296-299.
8. Uribarri J, Oh MS, Carroll HJ. Salt-losing nephropathy: clinical presentation and mechanisms. Am J Nephrol. 1983;3:193-198.
9. Portilla D, Andreoli TE. Disorders of extracellular volume. In: Johnson RJ, Feehally J, eds. Comprehensive clinical nephrology. London: Mosby International; 2007:77-91.
10. Better OS. Impaired fluid and electrolyte balance in hot climates. Kidney Int Suppl. 1987;21:S97-S101.
11. Antman EM. Hemodynamic disturbances. In: Libby P, Bonow R, Mann D, et al, eds. Braunwald's heart disease: a textbook of cardiac medicine. 8th ed. Philadelphia, PA: Saunders; 2008.
12. Powell-Tuck J, Gosling P, Lobo DN, et al. British consensus guidelines on intravenous fluid therapy for adult surgical patients. March 2011. http://www.bapen.org.uk/ (last accessed 25 August 2017).
13. Brienza N, Giglio MT, Marucci M, et al. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med. 2009;37:2079-2090.
14. Balk RA. Severe sepsis and septic shock: definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000;16:179-192.
15. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol. 2002;110:341-348.
16. Kramer GC, Kinsky MP, Prough DS, et al. Closed-loop control of fluid therapy for treatment of hypovolemia. J Trauma. 2008;64(suppl 4):S333-S341.
17. Guly H, Bouamra O, Spiers M, et al. Vital signs and estimated blood loss in patients with major trauma: testing the validity of the ATLS classification of hypovolaemic shock. Resuscitation. 2011;82:556-559.
18. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-1377.
19. Dellinger RP, Levy M, Carlet J, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
20. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
21. Peake SL, Delaney A, Bailey M, et al; ARISE Investigators; ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496-1506.
22. Yealy DM, Kellum JA, Huang DT, et al; ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683-1693.
23. Rivers E, Jaehne A, Eichhorn-Wharry L, et al. Fluid therapy in septic shock. Curr Opin Crit Care. 2010;16;297-308.
24. Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990;112:492-498.
25. Niemi T, Miyashita R, Yamakage M. Colloid solutions: a clinical update. J Anesth. 2010;24:913-925.
26. Andreoli TE. Edematous states: an overview. Kidney Int Suppl. 1997;59:S2-S10.
27. Bauer M, Feucht K, Ziegenfuss T, et al. Attenuation of shock-induced hepatic microcirculatory disturbances by the use of a starch-deferoxamine conjugate for resuscitation. Crit Care Med. 1995;23:316-322.
28. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ. 1998;316:961-964.
29. Roberts I, Blackhall K, Alderson, P, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011;(11):CD001208.
30. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;(2):CD000567.
31. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678-688.
32. Cappell MS, Friedel D. Initial management of acute upper gastrointestinal bleeding: from initial evaluation up to gastrointestinal endoscopy. Med Clin North Am. 2008;92:491-509.
33. Kellum JA. Acute kidney injury. Crit Care Med. 2008;36(suppl 4):S141-S145.
34. Duggan JM. Personal view: crystalloid transfusion in acute gastrointestinal haemorrhage: is it beneficial? An historical perspective. Aliment Pharmacol Ther. 2006;24:493-496.
35. Hambly PR, Dutton RP. Excess mortality associated with the use of rapid infusion at a level 1 trauma center. Resuscitation. 1996;31:127-133.
36. Charache S, Ness PM. Transfusion therapy. In: Stobo JD, Hellmann DB, Ladenson PW, et al, eds. The principles and practice of medicine. 23rd ed. New York, NY: McGraw-Hill Professional; 1996:761-768.
37. Hellstern P, Muntean W, Schramm W, et al. Practical guidelines for the clinical use of plasma. Thromb Res. 2002;107(suppl 1):S53-S57.
38. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013. http://www.ema.europa.eu/ (last accessed 25 August 2017).
39. Ipaktchi K, Arbabi S. Advances in burn critical care. Crit Care Med. 2006;34(suppl 9):S239-S244.
40. Bagshaw SM, Townsend DR, McDermid RC. Disorders of sodium and water balance in hospitalized patients. Can J Anaesth. 2009;56:151-167.
41. Kristensen AK, Holler JG, Hallas J, et al. Is shock index a valid predictor of mortality in emergency department patients with hypertension, diabetes, high age, or receipt of β- or calcium channel blockers? Ann Emerg Med. 2016;67:106-113.e6.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台